Roche’s Actemra Scores New Indication In Rare Autoimmune Disease
SSc-ILD Indication Comes With Biosimilar Competition On The Horizon
Roche received FDA approval for interstitial lung disease in the rare autoimmune disease systemic sclerosis • Source: Shutterstock 
